» Articles » PMID: 17098939

Concentration Dependent Selection of Targets by an SR Splicing Regulator Results in Tissue-specific RNA Processing

Overview
Specialty Biochemistry
Date 2006 Nov 14
PMID 17098939
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The splicing factor Transformer-2 (Tra2) is expressed almost ubiquitously in Drosophila adults, but participates in the tissue-specific regulation of splicing in several RNAs. In somatic tissues Tra2 participates in the activation of sex-specific splice sites in doublesex and fruitless pre-mRNAs. In the male germline it affects splicing of other transcripts and represses removal of the M1 intron from its own pre-mRNA. Here we test the hypothesis that the germline specificity of M1 repression is determined by tissue-specific differences in Tra2 concentration. We find that Tra2 is expressed at higher levels in primary spermatocytes of males than in other cell types. Increased Tra2 expression in other tissues reduces viability in a manner consistent with known dose-dependent effects of excessive Tra2 expression in the male germline. Somatic cells were found to be competent to repress M1 splicing if the level of Tra2 transcription was raised above endogenous concentrations. This suggests not only that M1 repression is restricted to the germline by a difference in Tra2 transcription levels but also that the protein's threshold concentration for M1 regulation differs from that of doublesex and fruitless RNAs. We propose that quantitative differences in regulator expression can give rise to cell-type-specific restrictions in splicing.

Citing Articles

Concentration and Localization of Coexpressed ELAV/Hu Proteins Control Specificity of mRNA Processing.

Zaharieva E, Haussmann I, Brauer U, Soller M Mol Cell Biol. 2015; 35(18):3104-15.

PMID: 26124284 PMC: 4539368. DOI: 10.1128/MCB.00473-15.


Half pint/Puf68 is required for negative regulation of splicing by the SR splicing factor Transformer2.

Wang S, Wagner E, Mattox W RNA Biol. 2013; 10(8):1396-406.

PMID: 23880637 PMC: 3817160. DOI: 10.4161/rna.25645.


Ets1 and heat shock factor 1 regulate transcription of the Transformer 2β gene in human colon cancer cells.

Kajita K, Kuwano Y, Kitamura N, Satake Y, Nishida K, Kurokawa K J Gastroenterol. 2013; 48(11):1222-33.

PMID: 23361474 DOI: 10.1007/s00535-012-0745-2.


Activation and repression functions of an SR splicing regulator depend on exonic versus intronic-binding position.

Shen M, Mattox W Nucleic Acids Res. 2011; 40(1):428-37.

PMID: 21914724 PMC: 3245930. DOI: 10.1093/nar/gkr713.


Molecular design of a splicing switch responsive to the RNA binding protein Tra2β.

Nagaraja Grellscheid S, Dalgliesh C, Rozanska A, Grellscheid D, Bourgeois C, Stevenin J Nucleic Acids Res. 2011; 39(18):8092-104.

PMID: 21724598 PMC: 3185414. DOI: 10.1093/nar/gkr495.


References
1.
Patton J, Mayer S, Tempst P, Nadal-Ginard B . Characterization and molecular cloning of polypyrimidine tract-binding protein: a component of a complex necessary for pre-mRNA splicing. Genes Dev. 1991; 5(7):1237-51. DOI: 10.1101/gad.5.7.1237. View

2.
Watermann D, Tang Y, Zur Hausen A, Jager M, Stamm S, Stickeler E . Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene. Cancer Res. 2006; 66(9):4774-80. DOI: 10.1158/0008-5472.CAN-04-3294. View

3.
Tian M, Maniatis T . A splicing enhancer complex controls alternative splicing of doublesex pre-mRNA. Cell. 1993; 74(1):105-14. DOI: 10.1016/0092-8674(93)90298-5. View

4.
Brand A, Perrimon N . Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993; 118(2):401-15. DOI: 10.1242/dev.118.2.401. View

5.
Amrein H, Hedley M, Maniatis T . The role of specific protein-RNA and protein-protein interactions in positive and negative control of pre-mRNA splicing by Transformer 2. Cell. 1994; 76(4):735-46. DOI: 10.1016/0092-8674(94)90512-6. View